An Open-label Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

Condition:   Inadequately Controlled Asthma
Intervention:   Biological: Tralokinumab open-label
Sponsor:   AstraZeneca
Not yet recruiting – verified September 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days